Levopropoxyphene
| Levopropoxyphene | |
|---|---|
|
(1R,2S)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl propionate |
|
|
Other names
[(2R,3S)-4-dimethylamino-3-methyl-1,2-diphenyl-butan-2-yl]propanoate |
|
| Identifiers | |
| CAS number | 2338-37-6 |
| PubChem | 200742 |
| ChemSpider | 173777 |
| ChEMBL | CHEMBL1213351 |
| Jmol-3D images | Image 1 |
|
|
|
|
| Properties | |
| Molecular formula | C22H29NO2 |
| Molar mass | 339.47 g mol−1 |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) |
|
| Infobox references | |
Levopropoxyphene is an antitussive. It is an optical isomer of dextropropoxyphene. The racemic mixture is called propoxyphene. Only the dextro-isomer (dextropropoxyphene) has an analgesic effect; the levo-isomer appears to exert only an antitussive effect. It was formerly marketed in the U.S. by Eli Lilly under the tradename Novrad as an antitussive.[1][2]
[edit] References
- ^ Reference.MD: Propoxyphene napsylate
- ^ Lutje Spelberg; Jeffrey Harald (2003). "Enantioselective biocatalytic conversions of epoxides". Rijksuniversiteit Groningen. http://irs.ub.rug.nl/ppn/242581676.
| This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |